Research Update

MORE THAN 50 MEDICINES IN DEVELOPMENT FOR COPD

Today, more than 13 million American adults suffer from COPD, one of

the most common lung diseases in the United States. COPD is a

progressive lower respiratory disease that encompasses two main

conditions – chronic bronchitis and emphysema. COPD is characterized

by obstructed airflow to the lungs that interferes with normal

breathing. People with COPD may be limited in their ability to work,

exercise and perform routine activities.

America€™s biopharmaceutical research companies are working on 54

medicines to treat COPD. According to a new report by the

Pharmaceutical Research and Manufacturers of America (PhRMA). These

exciting therapies are in late-stage development, meaning they are

either in clinical trials or awaiting review by the U.S. Food and

Drug Administration (FDA).

According to the National Institutes of Health (NIH), the number of

patients with COPD is increasing. In addition to those who have been

diagnosed with the disease, 12 million Americans likely have COPD

without knowing it. See More

innovation.org/index.cfm/Fu...

1 Reply

oldestnewest
  • February 2012 a small piece of history appreciate the effort.

You may also like...